Literature DB >> 25059730

Two cases of severe hidradenitis suppurativa with failure of anakinra therapy.

D Menis1, L Maroñas-Jiménez, A M Delgado-Marquez, C Postigo-Llorente, F Vanaclocha-Sebastián.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25059730     DOI： 10.1111/bjd.13292

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  9 in total

Review 1.  An Update on Medical Treatment Options for Hidradenitis Suppurativa.

Authors:  I E Deckers; E P Prens
Journal:  Drugs       Date:  2016-02       Impact factor: 9.546

Review 2.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

Review 3.  Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.

Authors:  Christina Fotiadou; Efstratios Vakirlis; Dimitrios Ioannides
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-10-19

Review 4.  Review of Current Immunologic Therapies for Hidradenitis Suppurativa.

Authors:  Victoria K Shanmugam; Nadia Meher Zaman; Sean McNish; Faye N Hant
Journal:  Int J Rheumatol       Date:  2017-08-20

Review 5.  Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.

Authors:  Gabriele Fenini; Emmanuel Contassot; Lars E French
Journal:  Front Pharmacol       Date:  2017-05-22       Impact factor: 5.810

Review 6.  Systematic review of immunomodulatory therapies for hidradenitis suppurativa.

Authors:  Shi Yu Derek Lim; Hazel H Oon
Journal:  Biologics       Date:  2019-05-13

7.  The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.

Authors:  A R J V Vossen; C B Ardon; H H van der Zee; E Lubberts; E P Prens
Journal:  Br J Dermatol       Date:  2019-04-12       Impact factor: 9.302

Review 8.  New and Emerging Targeted Therapies for Hidradenitis Suppurativa.

Authors:  Adela Markota Čagalj; Branka Marinović; Zrinka Bukvić Mokos
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

9.  Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy.

Authors:  Margaret M Lowe; Haley B Naik; Sean Clancy; Mariela Pauli; Kathleen M Smith; Yingtao Bi; Robert Dunstan; Johann E Gudjonsson; Maia Paul; Hobart Harris; Esther Kim; Uk Sok Shin; Richard Ahn; Wilson Liao; Scott L Hansen; Michael D Rosenblum
Journal:  JCI Insight       Date:  2020-10-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.